Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.904
+0.012 (1.35%)
At close: Jan 21, 2025, 4:00 PM
0.914
+0.010 (1.13%)
After-hours: Jan 21, 2025, 4:19 PM EST
Nektar Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$4.50
Upside
+397.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +619.03% | Jan 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +342.48% | Jan 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +674.34% | Nov 4, 2024 |
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +342.48% | Sep 30, 2024 |
| Jefferies | Jefferies | Hold Maintains $0.5 → $1 | Hold | Maintains | $0.5 → $1 | +10.62% | Mar 6, 2024 |
| JP Morgan | JP Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Nov 20, 2023 |
| TD Cowen | TD Cowen | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 9, 2023 |
| Mizuho | Mizuho | Hold Reiterates $6 | Hold | Reiterates | $6 | +563.72% | Aug 7, 2023 |
| Jefferies | Jefferies | Sell → Hold Upgrades $1.5 → $1 | Sell → Hold | Upgrades | $1.5 → $1 | +10.62% | May 10, 2023 |
| Oppenheimer | Oppenheimer | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +231.86% | Mar 6, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3 → $2 | Strong Sell | Maintains | $3 → $2 | +121.24% | Feb 27, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +231.86% | Feb 24, 2023 |
| Jefferies | Jefferies | Hold → Sell Downgrades $3.2 → $1.5 | Hold → Sell | Downgrades | $3.2 → $1.5 | +65.93% | Feb 24, 2023 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 8, 2022 |
| Jefferies | Jefferies | Hold Initiates $12 → $4 | Hold | Initiates | $12 → $4 | +342.48% | May 31, 2022 |
| Mizuho | Mizuho | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +563.72% | Apr 18, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.